Haploidentical BMT in Delhi

If your child or family member needs a bone marrow transplant but no fully matched donor has been found, a haploidentical (half-matched) transplant allows a parent, sibling, or child to donate, making treatment possible for nearly every patient. This page explains the procedure, donor eligibility, risks, cost, and recovery.

Quick Overview – Haploidentical BMT in Delhi

Learn more about a haploidentical bone marrow transplant in Delhi, including how donor matching works, what the procedure involves, and its role in treating serious blood disorders.

Introduction

When a child or adult is diagnosed with a serious blood disorder, a bone marrow transplant (BMT) is often the most important treatment step. But one of the first and most pressing challenges families face is finding the right donor. Not every patient has a fully matched sibling or an available unrelated donor on the registry.

This is where a haploidentical bone marrow transplant in Delhi has opened a significant door for patients and families.

A haploidentical stem cell transplant, commonly called a haplo BMT, uses a donor who is only a half (50%) genetic match to the patient. In most families, this means a parent, a child, or a sibling can serve as the donor, making it possible for nearly every patient to have someone eligible.

Delhi-based transplant specialists, including Dr. Satyendra Katewa at Max Super Speciality Hospital, Patparganj, evaluate patients individually and recommend the most appropriate transplant pathway based on the condition being treated and the donor available.

What Is Haploidentical Bone Marrow Transplant?

In simple terms, a haploidentical bone marrow transplant is a type of allogeneic (donor-based) transplant where the donor shares only half of the genetic markers called HLA (Human Leukocyte Antigens) required for a full match.

Our immune system uses HLA markers like a biological identity card. In an ideal world, a patient would have a donor who matches on all these markers.

In reality, only about 25-30% of patients find a fully matched sibling, and unrelated donor registries, though expanding in India, may not always have a suitable match for every case.

Haplo BMT bridges this gap. Here is how it compares to other transplant types:

The key advancement that made half-matched bone marrow transplant practical is improved post-transplant immunosuppression, particularly the use of post-transplant cyclophosphamide (PTCy), which helps the body accept the partially matched donor cells and reduces serious complications.

Who Can Be a Haploidentical Donor?

One of the most promising aspects of haplo BMT treatment in Delhi for families is that the donor is almost always someone close to the patient, a blood relative who is naturally a 50% genetic match.

Eligible haploidentical donors typically include:

• Parents – A mother or father is always a 50% match to their child
• Children – An adult child is always a 50% match to a parent
• Siblings – Brothers and sisters share, on average, a 50% genetic match (though some may be fully matched)
• Half-siblings, aunts, uncles, or cousins – May also qualify after HLA typing

Before being confirmed as a donor, the potential donor undergoes blood testing and HLA typing to confirm eligibility, as well as a full medical evaluation to ensure they are fit to donate.

This wide pool of potential donors is what makes a haploidentical transplant a practical option for most families, even when no fully matched donor is found.

Conditions Treated with Haploidentical BMT in Delhi

Haplo BMT is considered across a range of serious blood and bone marrow disorders when a transplant is clinically indicated. The decision to proceed is always made on a case-by-case basis after thorough specialist evaluation.

Conditions where a haploidentical transplant may be considered include:

• Thalassemia Major – One of the most common applications of haplo BMT for thalassemia in Delhi, where the only cure is a bone marrow transplant. Many children with thalassemia do not have a matched sibling, making haplo BMT a significant treatment pathway.

Learn more about blood disorders and anaemia management.

• Aplastic Anaemia – A condition where the bone marrow stops producing enough blood cells. Haploidentical transplant for aplastic anaemia is considered when other treatments have not succeeded, or a full-match donor is unavailable.
• Acute Leukaemia (ALL and AML) – Blood cancers where a transplant is recommended after remission to prevent relapse.

Learn more about blood cancer care.

• Lymphoma – Certain types of high-risk lymphoma may benefit from allogeneic transplant, including the haploidentical approach.
• Sickle Cell Disease – A transplant can offer a potential cure.

Read about sickle cell disease management on the website.

• Other bone marrow failure syndromes – Including inherited immune deficiencies and myelodysplastic syndromes (MDS).

Pediatric haploidentical transplant in Delhi is a particularly growing area, as children with conditions like thalassemia or leukaemia often need a transplant urgently and may not have the time for a long donor search.

Haploidentical BMT Procedure in Delhi – Step by Step

Understanding what the process looks like can help families feel more prepared. Here is a simplified overview of how the haploidentical BMT procedure in Delhi is carried out:

Step 1 – Pre-Transplant Evaluation

•  Before anything begins, both the patient and the potential donor undergo detailed testing.
• This includes blood tests, organ function tests, HLA typing, bone marrow biopsy, and imaging. The goal is to confirm that the patient is a good transplant candidate and the donor is eligible and healthy.

Step 2 – Donor HLA Typing and Confirmation

• The transplant team confirms the half-matched status through detailed HLA typing.
• A haploidentical match of at least 5/10 or 6/10 is generally required, and the donor must pass a health screening.

Step 3 – Conditioning Therapy

• Before receiving new stem cells, the patient undergoes conditioning – a preparatory phase using chemotherapy, sometimes combined with radiation.
• This serves two purposes: it makes space in the bone marrow for the new cells and suppresses the patient’s immune system so it does not reject the donor cells.

Learn about chemotherapy treatment in Delhi on the website.

Step 4 – Stem Cell Collection from the Donor

• The donor’s stem cells are collected either from the peripheral blood (after injections of a growth factor called G-CSF) or directly from the bone marrow under anaesthesia.
• The method is chosen based on the patient’s needs and the donor’s suitability.

Step 5 – Stem Cell Infusion

• The collected stem cells are infused into the patient through a central line, similar to a blood transfusion.
• This is a quiet, closely monitored process the stem cells travel to the bone marrow on their own.

Step 6 – Engraftment Phase

• Over the next 2-4 weeks, the transplant team monitors for engraftment, the point where the new stem cells start producing blood cells on their own.
• This is one of the most critical periods of recovery.

Step 7 – Post-Transplant Immunosuppression and Monitoring

• A key part of haplo BMT successis the post-transplant protocol.
• Medications like post-transplant cyclophosphamide (PTCy) and other immunosuppressants are given to reduce the risk of graft-versus-host disease (GVHD) without completely suppressing the graft-versus-disease (GVD) effect.

Advantages of Haploidentical Transplant

Families often ask: “Why choose a haploidentical bone marrow transplant over waiting for a full match?” Here are the factual, clinically relevant reasons:

• Wider donor availability – Nearly every patient has at least one eligible haploidentical donor in the immediate family
• Reduced waiting time – Searching unrelated donor registries can take weeks to months; a family donor can be evaluated quickly
• No donor registry fees – Family donors do not incur the costs associated with international bone marrow registries
• Emotional support – Having a family member as the donor can offer psychological comfort to patients, particularly children
• Option when no full match exists – For patients from rare ethnic backgrounds or those without siblings, haplo BMT may be the only allogeneic transplant option available

Risks and Important Considerations

Like any major medical procedure, haploidentical BMT carries risks that must be discussed openly with your transplant specialist. Being informed is an important part of the decision-making process.

Key risks include:

• Graft-versus-Host Disease (GVHD) – The donor’s immune cells may recognise the patient’s body as foreign and attack certain organs. Modern protocols have reduced severe GVHD, but it remains a monitored risk, both in an acute (early) and chronic (long-term) form.
• Graft Failure – In some cases, the new stem cells may not engraft successfully, requiring further intervention.
• Infections – During the period when the immune system is suppressed (between conditioning and engraftment), patients are vulnerable to bacterial, viral, and fungal infections. Strict infection control protocols are followed in transplant units.
• Organ-related side effects – Conditioning therapy can temporarily affect the liver, kidneys, and lungs. These are closely monitored throughout the process.
• Delayed immune recovery – Full immune reconstitution after a haplo BMT can take 6-12 months or longer, requiring ongoing precautions.

Your treating haploidentical transplant specialist in Delhi will explain each of these risks in the context of your specific case, the donor’s compatibility, and the condition being treated

Cost of Haploidentical BMT in Delhi

The cost of a haploidentical bone marrow transplant in Delhi is influenced by multiple factors. While it is difficult to give a single fixed number without a clinical evaluation, an approximate range can provide a starting point for planning.

Average cost range: ₹15 lakh to ₹30 lakh (indicative range; varies by case)

Factors that influence the cost include:

• The condition being treated and its stage/severity
• Pre-transplant evaluation investigations
• Duration of hospital stay and ICU requirement
• Medications, particularly immunosuppressants and anti-infectives
• Management of any post-transplant complications
• Follow-up care and long-term monitoring

Compared to an unrelated donor transplant, which may involve significant registry and coordination costs, a half-matched bone marrow transplant using a family donor can sometimes be more cost-effective, though medical costs remain significant.

For a detailed and transparent cost estimate specific to your case, you can refer to the bone marrow transplant cost in Delhi page or book a consultation directly.

Recovery After Haploidentical Transplant

Recovery from haplo BMT is a gradual process that takes place in phases:

In-Hospital Phase (4-6 weeks approximately)

• Patients remain admitted in a sterile transplant unit during conditioning, stem cell infusion, and the engraftment phase. Isolation precautions are maintained to minimise infection risk.

Early Post-Discharge Phase (3-6 months)

• After discharge, patients remain on immunosuppressive medications and require close monitoring.
• Regular blood counts, organ function tests, and clinic visits are essential. Activities are restricted, and exposure to crowded places or sick individuals must be avoided.

Long-Term Follow-Up (1 year and beyond)

• As the immune system recovers, most restrictions gradually ease.
• Vaccinations may be re-administered (since a transplant can reset vaccine immunity).
• Children who have undergone pediatric haploidentical transplant are monitored for growth, development, and school readiness in addition to medical parameters.

Your haematologist for bone marrow transplant in Delhi will provide a personalised recovery plan based on how engraftment progresses and any complications managed during the stay.

You can also explore Dr. Satyendra Katewa’s overall approach to BMT care for more context.

For additional therapies that may be used alongside transplant, explore immunotherapy and targeted therapy options available in Delhi.

Considering Haploidentical BMT in Delhi? Here’s Your Next Step

Finding out that your child or someone you love needs a bone marrow transplant is one of the most overwhelming moments a family can face. The medical terms are unfamiliar, the decisions feel huge, and the fear of not finding the right donor can make everything feel even more uncertain.

That is exactly why an early conversation with the right specialist matters so much.

Haploidentical BMT has made transplant possible for families who were once told no suitable donor exists. But every case is different: the condition, the donor’s compatibility, the timing, and the overall treatment plan all need to be done individually by someone with expertise and experience to guide you clearly and honestly.

Dr. Satyendra Katewa, Director of the Paediatric Haemato-Oncology and BMT Program at Max Healthcare, Patparganj, Delhi, has walked this path with families for over 25 years and more than 1,000 BMT cases. He understands that what families need is not just clinical expertise, but clarity, steady guidance, and a team that treats your child as more than a case file.

Whether you are just beginning to explore your options or need a second opinion on a transplant decision already in progress, a consultation can help you move forward with confidence.

👉 Book a Consultation | 👉 Learn About Bone Marrow Transplant in Delhi | 👉 View All Conditions Treated